{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,1,15]],"date-time":"2023-01-15T06:21:46Z","timestamp":1673763706092},"reference-count":11,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.3892\/mco.2017.1425","type":"journal-article","created":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T04:11:06Z","timestamp":1505794266000},"page":"855-858","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy of bendamustine on thrombocytopenia and hemolytic anemia secondary to CD5-positive B-cell lymphoma with massive splenomegaly in a patient with rheumatoid arthritis"],"prefix":"10.3892","volume":"7","author":[{"given":"Yuzuru","family":"Hosoda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Hagino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiko","family":"Hino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Motokura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,9,19]]},"reference":[{"key":"key20180107151338_b1-mco-0-0-1425","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1093\/annonc\/mdu365","article-title":"Autoimmune diseases associated with non-Hodgkin lymphoma: A nationwide cohort study","volume":"25","author":"Fallah","year":"2014","journal-title":"Ann Oncol"},{"key":"key20180107151338_b2-mco-0-0-1425","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00296-002-0229-4","article-title":"Malignant lymphoma-associated autoimmune diseases-a descriptive epidemiological study","volume":"22","author":"V\u00e1r\u00f3czy","year":"2002","journal-title":"Rheumatol Int"},{"key":"key20180107151338_b3-mco-0-0-1425","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4143\/crt.2012.44.1.69","article-title":"A case of Non-Hodgkin's lymphoma in patient with coombs' negative hemolytic anemia and idiopathic thrombocytopenic purpura","volume":"44","author":"Park","year":"2012","journal-title":"Cancer Res Treat"},{"key":"key20180107151338_b4-mco-0-0-1425","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1182\/blood-2009-04-215368","article-title":"The spectrum of Evans syndrome in adults: New insight into the disease based on the analysis of 68 cases","volume":"114","author":"Michel","year":"2009","journal-title":"Blood"},{"key":"key20180107151338_b5-mco-0-0-1425","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S0140-6736(12)61763-2","article-title":"Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: An open-label, multicentre, randomised, phase 3 non-inferiority trial","volume":"381","author":"Rummel","year":"2013","journal-title":"Lancet"},{"key":"key20180107151338_b6-mco-0-0-1425","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1182\/blood-2010-09-271437","article-title":"How I diagnose and treat splenic lymphomas","volume":"117","author":"Iannitto","year":"2011","journal-title":"Blood"},{"key":"key20180107151338_b7-mco-0-0-1425","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3892\/mco.2016.1063","article-title":"Pulmonary intravascular large B-cell lymphoma successfully treated with rituximab, cyclophosphamide, vincristine, doxorubicin and prednisolone immunochemotherapy: Report of a patient surviving for over 1 year","volume":"5","author":"Nishii-Ito","year":"2016","journal-title":"Mol Clin Oncol"},{"key":"key20180107151338_b8-mco-0-0-1425","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/1097-0142(19900115)65:2<349::AID-CNCR2820650228>3.0.CO;2-C","article-title":"Intravascular lymphomatosis presenting in the lung","volume":"65","author":"Yousem","year":"1990","journal-title":"Cancer"},{"key":"key20180107151338_b9-mco-0-0-1425","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1182\/blood-2016-03-704734","article-title":"Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia","volume":"128","author":"Mahevas","year":"2016","journal-title":"Blood"},{"key":"key20180107151338_b10-mco-0-0-1425","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/bjh.14049","article-title":"Rituximab, bendamustine and lenalidomide in patients with aggressive B-cell lymphoma not eligible for anthracycline-based therapy or intensive salvage chemotherapy-SAKK 38\/08","volume":"174","author":"Hitz","year":"2016","journal-title":"Br J Haematol"},{"key":"key20180107151338_b11-mco-0-0-1425","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1200\/JCO.2012.46.5203","article-title":"Multicenter phase II study of bendamustine plus rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma","volume":"31","author":"Ohmachi","year":"2013","journal-title":"J Clin Oncol"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T10:13:46Z","timestamp":1515320026000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mco.2017.1425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,19]]},"references-count":11,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,9,19]]},"published-print":{"date-parts":[[2017,11]]}},"alternative-id":["10.3892\/mco.2017.1425"],"URL":"https:\/\/doi.org\/10.3892\/mco.2017.1425","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,19]]}}}